Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus

被引:93
|
作者
Noah, TL [1 ]
Becker, S
机构
[1] Univ N Carolina, Div Pulm Med & Allergy, Dept Pediat, Chapel Hill, NC 27514 USA
[2] Univ N Carolina, Ctr Environm Med & Ling Biol, Chapel Hill, NC USA
[3] US EPA, Human Studies Div, Hlth Effects Res Lab, Res Triangle Pk, NC 27711 USA
关键词
RSV; IL-8; RANTES; MCP-1; MIP-1; alpha;
D O I
10.1006/clim.2000.4914
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The goal of this study was to determine time courses of upregulation of several chemokines in nasal secretions after inoculation of human subjects with a low dose of live respiratory syncytial virus (RSV). Healthy, nonsmoking young adults were admitted to an inpatient clinical research unit. After baseline studies, subjects were nasally inoculated with approximately 103 plaque-forming units of RSV (strain A2), followed by daily nasal lavages. Nasal lavage fluid (NLF) was assayed for chemokines by specific ELISA. Of 10 subjects inoculated with RSV, 3 developed clinical symptoms of upper respiratory infection and also shed virus. Among infected subjects, there was a transient postinoculation increase in interleukin-8 (IL-8) in NLF to an average of 2.7-fold compared to baseline, followed by a prolonged increase (maximum mean 5.4-fold) during virus shedding. RANTES, MLP-1 alpha, and MCP-1 all increased during virus shedding only (maximum mean increases of 5.3-fold, 13-fold, and 7.2-fold, respectively). Semiquantitative RT-PCR in brushed nasal epithelial cells on day 6 after inoculation suggested upregulation of RANTES, but not IL-8, mRNA during virus shedding. We conclude that chemokines IL-8, RANTES, MIP-1 alpha, and MCP-1 are all increased in nasal secretions in human RSV infection at the time of virus shedding and symptomatic illness and that the epithelium lining the nasal turbinate contributes to the increase in RANTES. (C) 2000 Academic Press.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 50 条
  • [21] Humulone suppresses replication of respiratory syncytial virus and release of IL-8 and RANTES in normal human nasal epithelial cells
    Fuchimoto, Jun
    Kojima, Takashi
    Okabayashi, Tamaki
    Masaki, Tomoyuki
    Ogasawara, Noriko
    Obata, Kazufumi
    Nomura, Kazuaki
    Hirakawa, Satoshi
    Kobayashi, Naoyuki
    Shigyo, Tatsuro
    Yokota, Shin-ichi
    Fujii, Nobuhiro
    Tsutsumi, Hiroyuki
    Himi, Tetsuo
    Sawada, Norimasa
    MEDICAL MOLECULAR MORPHOLOGY, 2013, 46 (04) : 203 - 209
  • [22] Humulone suppresses replication of respiratory syncytial virus and release of IL-8 and RANTES in normal human nasal epithelial cells
    Jun Fuchimoto
    Takashi Kojima
    Tamaki Okabayashi
    Tomoyuki Masaki
    Noriko Ogasawara
    Kazufumi Obata
    Kazuaki Nomura
    Satoshi Hirakawa
    Naoyuki Kobayashi
    Tatsuro Shigyo
    Shin-ichi Yokota
    Nobuhiro Fujii
    Hiroyuki Tsutsumi
    Tetsuo Himi
    Norimasa Sawada
    Medical Molecular Morphology, 2013, 46 : 203 - 209
  • [23] Reduced Nasal Viral Load and IFN Responses in Infants with Respiratory Syncytial Virus Bronchiolitis and Respiratory Failure
    Thwaites, Ryan S.
    Coates, Matthew
    Ito, Kazuhiro
    Ghazaly, Marwa
    Feather, Calandra
    Abdulla, Farhana
    Tunstall, Tanushree
    Jain, Pooja
    Cass, Lindsey
    Rapeport, Garth
    Hansel, Trevor T.
    Nadel, Simon
    Openshaw, Peter
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (08) : 1074 - 1084
  • [24] Respiratory syncytial virus hospitalization in middle-aged and older adults
    Malosh, Ryan E.
    Martin, Emily T.
    Callear, Amy P.
    Petrie, Joshua G.
    Lauring, Adam S.
    Lamerato, Lois
    Fry, Alicia M.
    Ferdinands, Jill
    Flannery, Brendan
    Monto, Arnold S.
    JOURNAL OF CLINICAL VIROLOGY, 2017, 96 : 37 - 43
  • [25] High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections
    Lee, N.
    Lui, G. C. Y.
    Wong, K. T.
    Li, T. C. M.
    Tse, E. C. M.
    Chan, J. Y. C.
    Yu, J.
    Wong, S. S. M.
    Choi, K. W.
    Wong, R. Y. K.
    Ngai, K. L. K.
    Hui, D. S. C.
    Chan, P. K. S.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (08) : 1069 - 1077
  • [26] Risk of mortality associated with respiratory syncytial virus and influenza infection in adults
    Kwon, Yong Shik
    Park, Sun Hyo
    Kim, Mi-Ae
    Kim, Hyun Jung
    Park, Jae Seok
    Lee, Mi Young
    Lee, Choong Won
    Dauti, Sonila
    Choi, Won-Il
    BMC INFECTIOUS DISEASES, 2017, 17
  • [27] INTENSIVE-CARE COURSE AND OUTCOME OF PATIENTS INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS
    STRETTON, M
    AJIZIAN, SJ
    MITCHELL, I
    NEWTH, CJL
    PEDIATRIC PULMONOLOGY, 1992, 13 (03) : 143 - 150
  • [28] Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments
    Bouzid, Donia
    Visseaux, Benoit
    Ferre, Valentine Marie
    Peiffer-Smadja, Nathan
    Le Hingrat, Quentin
    Loubet, Paul
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (12) : 1538 - 1550
  • [29] Characteristics of a respiratory syncytial virus persistently infected macrophage-like culture
    Sarmiento, RE
    Tirado, R
    Gómez, B
    VIRUS RESEARCH, 2002, 84 (1-2) : 45 - 58
  • [30] Improved detection of respiratory syncytial virus in nasal aspirates by seminested RT-PCR
    Henkel, JH
    Aberle, SW
    Kundi, M
    PopowKraupp, T
    JOURNAL OF MEDICAL VIROLOGY, 1997, 53 (04) : 366 - 371